
Keywords: AML; acute myeloid leukemia; BSA; bovine serum albumin; DPF; deferiprone (3-hydroxy-1,2-dimethyl-4-pyridinone); DFO; deferoxamine; ESA; erythropoietic stimulating agents; EDTA; ethylene-diamine tetracetate; FAC; ferric ammonium citrate; FIC; functional ir